Clinical Trial

Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2026 (before its estimated May 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
Compare the clinical performance and patient satisfaction of Egyptian MTA, Biodentine versus Calcium Hydroxide as indirect pulp capping materials in permanent teeth
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-09.
Status change: Not Yet Recruiting → Recruiting 2026-03-17
Trial Details
NCT Number NCT06683833
Lead Sponsor Cairo University
Conditions Deep Caries, Indirect Pulp Capping, Mineral Trioxide Aggregate (MTA), Calcium Hydroxide, Biodentine, Patient Reported Outcome Measures
Enrollment 35 participants
Start Date 2025-09-03
Primary Completion 2026-05-03 (estimated)
Study Completion 2026-07-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-18